Sign In
Buy BAX
$27.78
+0.230 (+0.83%)
At Close: Aug 10, 2026
BAX Stock Falls Following Q4 Earnings Miss, Margins Contract
12:05pm, Thursday, 12'th Feb 2026
Baxter International misses Q4 EPS estimates as margins shrink, even as revenues top forecasts; shares slide 12.5% on weak 2026 guidance.
Baxter (BAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31am, Thursday, 12'th Feb 2026
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Baxter International (BAX) Q4 Earnings Lag Estimates
09:35am, Thursday, 12'th Feb 2026
Baxter International (BAX) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.58 per share a year ago.
Baxter forecast 2026 profit below estimates
07:24am, Thursday, 12'th Feb 2026
Medical products maker Baxter forecast annual profit below Wall Street estimates on Thursday, due to persistent impact from hurricane-related disruptions at a key manufacturing unit.
Baxter Reports Fourth-Quarter 2025 Results
07:15am, Thursday, 12'th Feb 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025. “While we delivered sales growth across all se
Baxter to Post Q4 Earnings: What's in Store for the Stock?
02:31pm, Tuesday, 10'th Feb 2026
BAX's fourth-quarter results are likely to reflect muted revenue growth and an EPS decline due to ongoing infusion therapy and IV fluid headwinds.
Seeking Clues to Baxter (BAX) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:15am, Tuesday, 10'th Feb 2026
Beyond analysts' top-and-bottom-line estimates for Baxter (BAX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter en
Richard Pzena's Strategic Moves: A Closer Look at PPG Industries Inc.
05:02pm, Friday, 06'th Feb 2026
Insights from the Fourth Quarter 2025 13F Filing Richard Pzena (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing
Is Baxter International an Underrated Healthcare Investment Play?
10:15am, Friday, 06'th Feb 2026
Baxter International sells medical products and devices. The company's products are necessities for the healthcare industry.
Baxter International (NYSE:BAX) vs. Hero Technologies (OTCMKTS:HENC) Financial Analysis
01:34am, Thursday, 05'th Feb 2026
Baxter International (NYSE: BAX - Get Free Report) and Hero Technologies (OTCMKTS:HENC - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two busin
Richard Pzena's Strategic Acquisition of Tyson Foods Shares
07:31pm, Wednesday, 04'th Feb 2026
Significant Transaction in Tyson Foods On December 31, 2025, Richard Pzena (Trades, Portfolio) executed a notable transaction involving Tyson Foods Inc. The fir
Reasons to Retain Baxter International Stock in Your Portfolio Now
09:26am, Wednesday, 28'th Jan 2026
BAX is reshaping its portfolio following the divestiture of its Kidney Care business, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum.
Baxter International Inc. $BAX Shares Purchased by Cooke & Bieler LP
05:12am, Monday, 26'th Jan 2026
Cooke and Bieler LP boosted its holdings in Baxter International Inc. (NYSE: BAX) by 25.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange
Richard Pzena's Strategic Acquisition of Malibu Boats Inc Shares
09:44am, Thursday, 22'nd Jan 2026
On December 31, 2025, Richard Pzena (Trades, Portfolio), a prominent figure in the investment world, executed a significant stock transaction involving Malibu B
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors
05:00pm, Wednesday, 21'st Jan 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday,
